SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-020865
Filing Date
2024-05-21
Accepted
2024-05-21 15:06:47
Documents
21
Period of Report
2024-05-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 55004
2 ex3-16.htm EX-3.16 1824
3 ex3-17.htm EX-3.17 35108
4 ex3-18.htm EX-3.18 32648
5 ex10-109.htm EX-10.109 277004
6 ex3-16_001.jpg GRAPHIC 146864
7 ex3-16_002.jpg GRAPHIC 272410
8 ex3-17_001.jpg GRAPHIC 502533
9 ex3-18_001.jpg GRAPHIC 488391
  Complete submission text file 0001493152-24-020865.txt   2585142

Data Files

Seq Description Document Type Size
10 XBRL SCHEMA FILE jan-20240515.xsd EX-101.SCH 3006
11 XBRL LABEL FILE jan-20240515_lab.xml EX-101.LAB 34240
12 XBRL PRESENTATION FILE jan-20240515_pre.xml EX-101.PRE 22354
24 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3680
Mailing Address 325 E. WARM SPRINGS ROAD SUITE 102 LAS VEGAS NV 89119
Business Address 325 E. WARM SPRINGS ROAD SUITE 102 LAS VEGAS NV 89119 702-997-5968
JanOne Inc. (Filer) CIK: 0000862861 (see all company filings)

IRS No.: 411454591 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19621 | Film No.: 24968831
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)